LUNAI BIOWORKS, INC. — Income Charts
52 quarters of history · ending 2023-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+429.5% +$13K
$16K
Cost of Revenue
$31
Gross Profit
$213
R&D↑+90.4% +$295K
$621K
D&A↑+15.0% +$4K
$33K
Operating Income↑+2.2% +$98K
$-4M
EBITDA↑+2.4% +$102K
$-4M
Interest Expense↑+196.0% +$182K
$275K
Interest Income↓-64.5% -$5K
$3K
Other Income/Expense↑+73.4% +$308K
$-112K
Pretax Income↓-19.2% -$1M
$-9M
Tax Provision
$0
Net Income↓-1.6% -$71K
$-5M
Gross Margin
87.7%
Operating Margin↑+118320.0pts
-26791.8%
Net Margin↑+119680.8pts
-28417.1%
Effective Tax Rate↓-0.0pts
0.0%
DTA Valuation Allowance↑+98.5% +$70M
$142M
NOL Carryforwards↑+101.1% +$69M
$138M
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
-34.0%
Operating Lease Cost↓-37.0% -$36K
$61K
Revenue YoY Variation
429.5%
Income YoY Variation↓-28.8pts
2.2%
Revenue QoQ Variation↑+136.8pts
90.3%
Income QoQ Variation↑+12.7pts
51.9%